Blue Owl Capital Complete Acquisition Of Spire Healthcare Portfolio

By Amit Chowdhry • Today at 8:07 AM

Blue Owl Capital announced that funds managed by the firm, together with Moor Park Capital Partners, completed the acquisition of a portfolio of 12 acute-care hospitals operated by Spire Healthcare Group.

Spire Healthcare is a leading private hospital operator in the U.K. The acquisition adds a portfolio of healthcare real estate assets supported by long-term leases with a market-leading tenant.

Blue Owl said the transaction significantly accelerates the expansion of its European Net Lease strategy. The deal also reflects the firm’s broader focus on expanding its Real Assets platform across essential real estate sectors.

The Spire portfolio will be part of Blue Owl’s Real Assets platform. Blue Owl said the assets will benefit from the firm’s institutional scale, investment expertise, and long-standing real estate market relationships.

Blue Owl and Moor Park said they see additional opportunities for growth in the European healthcare sector. The firms plan to continue pursuing opportunities in the space that offer compelling risk-adjusted returns.

The acquisition was financed by a new secured term loan. Standard Chartered Bank, Natixis, and Crédit Agricole CIB acted as joint mandated lead arrangers and lenders for the transaction.

Rothschild & Co served as Blue Owl’s exclusive financial advisor. Kirkland & Ellis and Hogan Lovells served as legal counsel to Blue Owl, while Deloitte served as tax and financial due diligence advisor.

Blue Owl had $315 billion in assets under management as of March 31, 2026. The firm invests across Credit, Real Assets, and GP Strategic Capital.

KEY QUOTES:

“The acquisition of the Spire portfolio represents a strategic investment in a portfolio of high-quality UK private hospitals with a market leading tenant, well-structured long-term leases and significantly accelerates the expansion of our European Net Lease strategy. This transaction builds on the firm’s experience investing across the healthcare landscape and represents an opportunity to capitalize on the strong supply and demand fundamentals in the European healthcare real estate sector while delivering what we believe to be compelling value for investors and the communities these facilities serve.”

Marc Zahr, Co-President and Global Head of Real Assets at Blue Owl